Is quetiapine suitable for treatment of acute schizophrenia with catatonic stupor? Aa case series of 39 patients

Bunta Yoshimura, Tomoya Hirota, Manabu Takaki, Yoshiki Kishi

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Purpose: We aimed to determine which antipsychotic is most effective for the treatment of acute schizophrenia with catatonic stupor. Patients and methods: Data were obtained from the medical records of 450 patients with the diagnosis of schizophrenia, who had received acute psychiatric inpatient treatment between January 2008 and December 2010 at our hospital. Among them, 39 patients (8.7%) met the definition of catatonic stupor during hospitalization. The diagnoses of schizophrenia in all 39 patients were reconfirmed during the maintenance phase. We retrospectively reviewed the medical records of these 39 patients to investigate which antipsychotics were chosen for treatment during the period from admission to recovery from catatonia, at the time of discharge, and 12 and 30 months after discharge. Results: As compared to other antipsychotics, it was found out that use of quetiapine had better outcomes and hence was used more often. A total of 61.5% of patients were on quetiapine at the time of recovery from catatonia and 51.3% of patients were on quetiapine at the time of discharge as compared to only 17.9% of patients on quetiapine on admission. However, at 12 and 30 months after discharge, the rates had decreased to 38.4% and 25.6%. Similarly, of 29 patients who were not administered electroconvulsive therapy, quetiapine was used at significantly higher rates at the time of recovery from catatonia (48.3%) than at the time of admission (17.2%). All 39 patients had received an antipsychotic as the first-line treatment and some antipsychotics might have contributed to the development of catatonia. Conclusion: This study suggests that quetiapine is a promising agent for the treatment of schizophrenia with catatonic stupor during the acute phase.

Original languageEnglish
Pages (from-to)1565-1571
Number of pages7
JournalNeuropsychiatric Disease and Treatment
Volume9
DOIs
Publication statusPublished - Oct 9 2013

Fingerprint

Catatonic Schizophrenia
Stupor
Catatonia
Antipsychotic Agents
Therapeutics
Medical Records
Schizophrenia
Quetiapine Fumarate
Electroconvulsive Therapy
Psychiatry
Inpatients

Keywords

  • Catatonia
  • Electroconvulsive therapy
  • Quetiapine
  • Schizophrenia
  • Stupor

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Is quetiapine suitable for treatment of acute schizophrenia with catatonic stupor? Aa case series of 39 patients. / Yoshimura, Bunta; Hirota, Tomoya; Takaki, Manabu; Kishi, Yoshiki.

In: Neuropsychiatric Disease and Treatment, Vol. 9, 09.10.2013, p. 1565-1571.

Research output: Contribution to journalArticle

@article{11c1af3e9b7144a0ba86243272cbd691,
title = "Is quetiapine suitable for treatment of acute schizophrenia with catatonic stupor? Aa case series of 39 patients",
abstract = "Purpose: We aimed to determine which antipsychotic is most effective for the treatment of acute schizophrenia with catatonic stupor. Patients and methods: Data were obtained from the medical records of 450 patients with the diagnosis of schizophrenia, who had received acute psychiatric inpatient treatment between January 2008 and December 2010 at our hospital. Among them, 39 patients (8.7{\%}) met the definition of catatonic stupor during hospitalization. The diagnoses of schizophrenia in all 39 patients were reconfirmed during the maintenance phase. We retrospectively reviewed the medical records of these 39 patients to investigate which antipsychotics were chosen for treatment during the period from admission to recovery from catatonia, at the time of discharge, and 12 and 30 months after discharge. Results: As compared to other antipsychotics, it was found out that use of quetiapine had better outcomes and hence was used more often. A total of 61.5{\%} of patients were on quetiapine at the time of recovery from catatonia and 51.3{\%} of patients were on quetiapine at the time of discharge as compared to only 17.9{\%} of patients on quetiapine on admission. However, at 12 and 30 months after discharge, the rates had decreased to 38.4{\%} and 25.6{\%}. Similarly, of 29 patients who were not administered electroconvulsive therapy, quetiapine was used at significantly higher rates at the time of recovery from catatonia (48.3{\%}) than at the time of admission (17.2{\%}). All 39 patients had received an antipsychotic as the first-line treatment and some antipsychotics might have contributed to the development of catatonia. Conclusion: This study suggests that quetiapine is a promising agent for the treatment of schizophrenia with catatonic stupor during the acute phase.",
keywords = "Catatonia, Electroconvulsive therapy, Quetiapine, Schizophrenia, Stupor",
author = "Bunta Yoshimura and Tomoya Hirota and Manabu Takaki and Yoshiki Kishi",
year = "2013",
month = "10",
day = "9",
doi = "10.2147/NDT.S52311",
language = "English",
volume = "9",
pages = "1565--1571",
journal = "Neuropsychiatric Disease and Treatment",
issn = "1176-6328",
publisher = "Dove Medical Press Ltd.",

}

TY - JOUR

T1 - Is quetiapine suitable for treatment of acute schizophrenia with catatonic stupor? Aa case series of 39 patients

AU - Yoshimura, Bunta

AU - Hirota, Tomoya

AU - Takaki, Manabu

AU - Kishi, Yoshiki

PY - 2013/10/9

Y1 - 2013/10/9

N2 - Purpose: We aimed to determine which antipsychotic is most effective for the treatment of acute schizophrenia with catatonic stupor. Patients and methods: Data were obtained from the medical records of 450 patients with the diagnosis of schizophrenia, who had received acute psychiatric inpatient treatment between January 2008 and December 2010 at our hospital. Among them, 39 patients (8.7%) met the definition of catatonic stupor during hospitalization. The diagnoses of schizophrenia in all 39 patients were reconfirmed during the maintenance phase. We retrospectively reviewed the medical records of these 39 patients to investigate which antipsychotics were chosen for treatment during the period from admission to recovery from catatonia, at the time of discharge, and 12 and 30 months after discharge. Results: As compared to other antipsychotics, it was found out that use of quetiapine had better outcomes and hence was used more often. A total of 61.5% of patients were on quetiapine at the time of recovery from catatonia and 51.3% of patients were on quetiapine at the time of discharge as compared to only 17.9% of patients on quetiapine on admission. However, at 12 and 30 months after discharge, the rates had decreased to 38.4% and 25.6%. Similarly, of 29 patients who were not administered electroconvulsive therapy, quetiapine was used at significantly higher rates at the time of recovery from catatonia (48.3%) than at the time of admission (17.2%). All 39 patients had received an antipsychotic as the first-line treatment and some antipsychotics might have contributed to the development of catatonia. Conclusion: This study suggests that quetiapine is a promising agent for the treatment of schizophrenia with catatonic stupor during the acute phase.

AB - Purpose: We aimed to determine which antipsychotic is most effective for the treatment of acute schizophrenia with catatonic stupor. Patients and methods: Data were obtained from the medical records of 450 patients with the diagnosis of schizophrenia, who had received acute psychiatric inpatient treatment between January 2008 and December 2010 at our hospital. Among them, 39 patients (8.7%) met the definition of catatonic stupor during hospitalization. The diagnoses of schizophrenia in all 39 patients were reconfirmed during the maintenance phase. We retrospectively reviewed the medical records of these 39 patients to investigate which antipsychotics were chosen for treatment during the period from admission to recovery from catatonia, at the time of discharge, and 12 and 30 months after discharge. Results: As compared to other antipsychotics, it was found out that use of quetiapine had better outcomes and hence was used more often. A total of 61.5% of patients were on quetiapine at the time of recovery from catatonia and 51.3% of patients were on quetiapine at the time of discharge as compared to only 17.9% of patients on quetiapine on admission. However, at 12 and 30 months after discharge, the rates had decreased to 38.4% and 25.6%. Similarly, of 29 patients who were not administered electroconvulsive therapy, quetiapine was used at significantly higher rates at the time of recovery from catatonia (48.3%) than at the time of admission (17.2%). All 39 patients had received an antipsychotic as the first-line treatment and some antipsychotics might have contributed to the development of catatonia. Conclusion: This study suggests that quetiapine is a promising agent for the treatment of schizophrenia with catatonic stupor during the acute phase.

KW - Catatonia

KW - Electroconvulsive therapy

KW - Quetiapine

KW - Schizophrenia

KW - Stupor

UR - http://www.scopus.com/inward/record.url?scp=84885456051&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885456051&partnerID=8YFLogxK

U2 - 10.2147/NDT.S52311

DO - 10.2147/NDT.S52311

M3 - Article

C2 - 24143105

AN - SCOPUS:84885456051

VL - 9

SP - 1565

EP - 1571

JO - Neuropsychiatric Disease and Treatment

JF - Neuropsychiatric Disease and Treatment

SN - 1176-6328

ER -